AMPARO C contact VILLABLANCA

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Coronary heart disease in women. Gender differences and effects of menopause
    A C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, School of Medicine 95616, USA
    Postgrad Med 100:191-6, 201-2. 1996
  2. ncbi Atherosclerosis and sex hormones: current concepts
    Amparo C Villablanca
    Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis, Davis, CA 95616, USA
    Clin Sci (Lond) 119:493-513. 2010
  3. ncbi Maternal and neonatal exposure to environmental tobacco smoke targets pro-inflammatory genes in neonatal arteries
    Amparo C Villablanca
    Department of Internal Medicine, University of California Davis, One Shields Avenue, Davis, CA 95616 8636, USA
    J Cardiovasc Transl Res 3:696-703. 2010
  4. ncbi Outcomes of comprehensive heart care programs in high-risk women
    Amparo C Villablanca
    University of California, Davis, California 95616 8636, USA
    J Womens Health (Larchmt) 19:1313-25. 2010
  5. ncbi 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice
    Amparo C Villablanca
    Department of Internal Medicine, University of California, Davis, Davis, CA, USA
    J Cardiovasc Transl Res 2:289-99. 2009
  6. ncbi Outcomes of national community organization cardiovascular prevention programs for high-risk women
    Amparo C Villablanca
    Cardiovascular Medicine, University of California, Davis, One Shields Ave, TB 172, Davis, CA 95616 8636, USA
    J Cardiovasc Transl Res 2:306-20. 2009
  7. ncbi Career flexibility and family-friendly policies: an NIH-funded study to enhance women's careers in biomedical sciences
    Amparo C Villablanca
    Department of Internal Medicine, University of California, Davis, California, USA
    J Womens Health (Larchmt) 20:1485-96. 2011
  8. ncbi Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha
    Amparo Villablanca
    Department of Internal Medicine, University of California, Davis, One Shields Ave, TB 172, Davis, CA 95616 8636, USA
    Arterioscler Thromb Vasc Biol 24:1055-61. 2004
  9. ncbi Differential regulation of gene expression by ovariectomy in mouse aorta
    Amparo C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, California 95616 8636, USA
    Physiol Genomics 12:175-85. 2003
  10. ncbi 17beta-estradiol stimulates substance P receptor gene expression
    A C Villablanca
    Department of Internal Medicine, University of California, Davis 95616, USA
    Mol Cell Endocrinol 135:109-17. 1997

Research Grants

  1. GENETIC MECHANISMS OF ESTROGEN ATHEROPROTECTION
    Amparo Villablanca; Fiscal Year: 2003
  2. Women's Careers in the Medical Sciences and Family Friendly Policies
    Amparo Villablanca; Fiscal Year: 2009
  3. Women's Careers in the Medical Sciences and Family Friendly Policies
    AMPARO C contact VILLABLANCA; Fiscal Year: 2010

Collaborators

Detail Information

Publications20

  1. ncbi Coronary heart disease in women. Gender differences and effects of menopause
    A C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, School of Medicine 95616, USA
    Postgrad Med 100:191-6, 201-2. 1996
    ..An understanding of gender differences in CHD, together with new data from current and future investigative studies, should lead to improved outcomes for women with CHD...
  2. ncbi Atherosclerosis and sex hormones: current concepts
    Amparo C Villablanca
    Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis, Davis, CA 95616, USA
    Clin Sci (Lond) 119:493-513. 2010
    ..Future studies in this field will contribute to guiding clinical treatment recommendations for women and help define research priorities...
  3. ncbi Maternal and neonatal exposure to environmental tobacco smoke targets pro-inflammatory genes in neonatal arteries
    Amparo C Villablanca
    Department of Internal Medicine, University of California Davis, One Shields Avenue, Davis, CA 95616 8636, USA
    J Cardiovasc Transl Res 3:696-703. 2010
    ..Prenatal and postnatal exposure to ETS increases expression of pro-inflammatory genes and may be responsible for early arterial vascular remodeling that is predisposing to a subsequent vascular disease...
  4. ncbi Outcomes of comprehensive heart care programs in high-risk women
    Amparo C Villablanca
    University of California, Davis, California 95616 8636, USA
    J Womens Health (Larchmt) 19:1313-25. 2010
    ..The purpose of this study was to improve the fund of knowledge, reduce cardiovascular disease (CVD) risk, and attain Healthy People 2010 objectives among women in model women's heart programs...
  5. ncbi 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice
    Amparo C Villablanca
    Department of Internal Medicine, University of California, Davis, Davis, CA, USA
    J Cardiovasc Transl Res 2:289-99. 2009
    ..Our findings may contribute to future improved clinical decision-making concerning the use of hormone therapy...
  6. ncbi Outcomes of national community organization cardiovascular prevention programs for high-risk women
    Amparo C Villablanca
    Cardiovascular Medicine, University of California, Davis, One Shields Ave, TB 172, Davis, CA 95616 8636, USA
    J Cardiovasc Transl Res 2:306-20. 2009
    ....
  7. ncbi Career flexibility and family-friendly policies: an NIH-funded study to enhance women's careers in biomedical sciences
    Amparo C Villablanca
    Department of Internal Medicine, University of California, Davis, California, USA
    J Womens Health (Larchmt) 20:1485-96. 2011
    ....
  8. ncbi Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha
    Amparo Villablanca
    Department of Internal Medicine, University of California, Davis, One Shields Ave, TB 172, Davis, CA 95616 8636, USA
    Arterioscler Thromb Vasc Biol 24:1055-61. 2004
    ..Their role in early atherosclerosis remains poorly understood, particularly in males. We developed and characterized an atherosclerosis model in ERalpha knockout male mice to investigate directly its role in atheroma...
  9. ncbi Differential regulation of gene expression by ovariectomy in mouse aorta
    Amparo C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, California 95616 8636, USA
    Physiol Genomics 12:175-85. 2003
    ..These studies have implications for our understanding of hormonal regulation of vascular gene expression and the therapeutic targeting of specific vascular genetic sequences by female sex steroid hormones...
  10. ncbi 17beta-estradiol stimulates substance P receptor gene expression
    A C Villablanca
    Department of Internal Medicine, University of California, Davis 95616, USA
    Mol Cell Endocrinol 135:109-17. 1997
    ..Increased SPR mRNA levels in response to E2 were linearly related to increased [3H]SP binding to the SPR. This study has implications for understanding molecular mechanisms of hormonal control of receptor gene expression...
  11. ncbi Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro
    A C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, California 95616, USA
    J Appl Physiol 84:2089-98. 1998
    ..This study has implications for understanding cellular mechanisms of nicotine action. The results may be important in tumor angiogenesis, atherogenesis, and vascular dysfunction in smokers...
  12. ncbi Heart disease during pregnancy. Which cardiovascular changes are normal or transient?
    A C Villablanca
    Division of Cardiovascular Medicine, University of California, School of Medicine, Davis 90272, USA
    Postgrad Med 104:183-4, 187-92. 1998
    ..Hypertension, one of the most common complications of pregnancy, may be transient and benign, or it may be chronic or gestational. Early recognition and intervention are beneficial to both the mother and the child...
  13. ncbi Heart disease during pregnancy. Which cardiovascular changes reflect disease?
    A C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, School of Medicine 90272, USA
    Postgrad Med 104:149-56. 1998
    ..Pregnancy in women with prosthetic cardiac valves may expose mother and child to risks that can be minimized with appropriate safeguards...
  14. ncbi Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women
    Francene M Steinberg
    Department of Nutrition, University of California, Davis, 95616, USA
    Am J Clin Nutr 78:123-30. 2003
    ..Controversy exists about the ability of soy protein and isoflavones to modulate vascular reactivity and biochemical cardiovascular disease risk markers in healthy, normolipidemic postmenopausal women...
  15. ncbi Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens
    Radhika Nandur
    Division of Cardiovascular Medicine, University of California, Davis, Davis, CA 95616, USA
    Prev Cardiol 7:73-9. 2004
    ..In addition, the authors' current understanding of the mechanism of action of these agents is discussed and recommendations for clinical practice are reviewed...
  16. ncbi Compromised aortic vasoreactivity in male estrogen receptor-alpha-deficient mice during acute lipopolysaccharide-induced inflammation
    Ana M Corbacho
    Center for Biophotonics Science and Technology CBST, University of California Davis, One Shields Avenue, Hunt Hall 225, Davis, CA 95616, USA
    Endocrinology 148:1403-11. 2007
    ..e. endothelial NOS) and the vascular responses to NO (i.e. soluble guanylate cyclase)...
  17. ncbi Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women
    Janice F Wang-Polagruto
    Department of Nutrition, University of California, Davis, CA 95616, USA
    J Cardiovasc Pharmacol 47:S177-86; discussion S206-9. 2006
    ..In addition, our results suggest that reductions in plasma soluble vascular cell adhesion molecule-1 after chronic consumption of a flavanol-rich cocoa may be mechanistically linked to improved vascular reactivity...
  18. ncbi Time- and dose-dependent differential upregulation of three genes by 17 beta-estradiol in endothelial cells
    Amparo C Villablanca
    Division of Cardiovascular Medicine, University of California, Davis, California 95616 8636, USA
    J Appl Physiol 92:1064-73. 2002
    ..Our results describe previously uncharacterized estradiol-sensitive time- and dose-dependent regulation of genes with potential importance to vascular function in human endothelial cells...
  19. ncbi Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
    Jeana Benton
    School of Medicine, University of California, Davis, CA 95616, USA
    Am J Physiol Regul Integr Comp Physiol 292:R723-30. 2007
    ....
  20. ncbi Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause?
    Abraham A Ariyo
    Division of Cardiovascular Medicine, University of California, Davis, Medical Center, Sacramento, USA
    Postgrad Med 111:23-30; quiz 3. 2002
    ..Nonetheless, physicians should consider the use of HRT, SERMs, and phytoestrogens for lowering lipid levels and reducing cardiovascular risk in women...

Research Grants3

  1. GENETIC MECHANISMS OF ESTROGEN ATHEROPROTECTION
    Amparo Villablanca; Fiscal Year: 2003
    ..Advances in our basic understanding of mechanisms of hormone action could lead to more effective strategies for treatment of coronary artery disease in both men and women. ..
  2. Women's Careers in the Medical Sciences and Family Friendly Policies
    Amparo Villablanca; Fiscal Year: 2009
    ....
  3. Women's Careers in the Medical Sciences and Family Friendly Policies
    AMPARO C contact VILLABLANCA; Fiscal Year: 2010
    ....